Joel Greenblatt · Magic Formula: alto retorno sobre o capital a um EV/EBIT baixo
Is Xeris Biopharma Holdings, Inc. (XERS) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
52/100
Misto
1/5 critérios atendidos
Os critérios de Joel Greenblatt, aplicados a XERS
EBIT/EV yield ≥ 10%
chave2.4%
ROIC ≥ 25%
chave12.8%
EV/EBIT ≤ 12
42.3x
Gross margin ≥ 30%
81.6%
Como XERS pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$1.66B
P/L (TTM)
92.7x
ROIC (TTM)
12.84%
Margem bruta
81.59%
Outras análises Joel Greenblatt
Perguntas frequentes
What is XERS's Joel Greenblatt fit score?
XERS scores 52/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own XERS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends XERS.
How often is this score updated?
XERS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Joel Greenblatt possua ou recomende XERS pessoalmente.
